Timely diagnosis and effective treatment of diabetic polyneuropathy are important for patients with diabetes mellitus.
The aim of the study was to increase the effectiveness of treatment of tactile, vibrational, pain and temperature sensitivity by incorporating the drug Keltican and polarizing light into the complex therapy of diabetic polyneuropathy.
Research results 130 patients with type 2 diabetes mellitus, complicated by diabetic polyneuropathy were examined. Patients were divided into 4 groups: 32 patients received standard treatment in group 1, 32 patients in group 2 additionally received 1 capsule of Keltican three times a day for one month. 12 therapeutic procedures with polarizing light were additionally assigned for 35 diabetics of group 3. 31 patients in the 4th group, in addition to standard treatment, received both Keltican and a course of polarizing light therapy at the same time.
Evaluation of vibration, tactile, pain and temperature sensitivity was performed using tuning fork, monofilament, atraumatic needle and Tip-Term cylinder respectively.
In the initial state, a significant decrease was observed mainly in vibration and tactile sensitivity. The use of the proposed treatment programs has shown its positive clinical effect in the groups of patients. Patients receiving standard therapy veritably recovered only in pain sensation. Patients who were additionally assigned keltican showed an improvement in temperature, pain and tactile sensitivity. The best clinical effect of treatment (a reliable restoration of all types of sensitivity) was achieved in patients who, in addition to standard therapy, received light therapy treatment or its combination with keltican.
Conclusions the use of keltican and light therapy (polarizing light) in the complex treatment of diabetic polyneuropathy contributes to more effective restoration of sensory impairment in patients with diabetes mellitus.